<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04187651</url>
  </required_header>
  <id_info>
    <org_study_id>PRPF</org_study_id>
    <nct_id>NCT04187651</nct_id>
  </id_info>
  <brief_title>PRP Use in Treatment of Fistula Ano</brief_title>
  <official_title>Use of Platelet Rich Plasma in Treatment of Perianal Fistula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uşak University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uşak University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In treatment of perianal fistula several methods are described. However, since the
      Hippocrates basics of surgical treatment has not changed very much. the aim of this study is
      to evaluate the effectiveness of PRP gel in treatment of perianal fistula.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Perianal fistula is a chronic condition that seriously affects the patients' quality of life.
      There are different treatment modalities used in treatment. Recently sphincter preserving
      methods are becoming more popular with low complication rates. Most of this methods aiming
      the closure of fistula tract by different pathways.

      Platelet rich plasma (PRP) is used in a wide range of conditions in medicine. The
      investigator's team showed the effective treatment of pilonidal disease by use of PRP gel. In
      the recent study, aim to evaluate the effectiveness of PRP gel in treatment of perianal
      fistula.

      Patients with perianal fistula will be evaluated for the study. After taking permission with
      informed consent; cases will be included in the study. Cases with inflammatory bowel disease,
      platelet function disorders or connective tissue disorders that may alter wound healing will
      be excluded from the study.

      After, PRP application to the fistula tract patients will be taken to follow up. Perianal
      fistulas will be followed by magnetic resonance imaging 1 month after the application.
      Pre-application and post-application scans will be used for the evaluation of the treatment
      success.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>PRP gel will be applicated to all cases</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of the cure rate</measure>
    <time_frame>1 month</time_frame>
    <description>closure of the fistula tract will be evaluated by physical examination and magnetic resonance imaging</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Fistula in Ano</condition>
  <arm_group>
    <arm_group_label>PRP gel application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PRP application for perianal fistula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>platelet rich plasma</intervention_name>
    <description>platelet rich plasma prepared from the patients' own blood will be applied to the fistula tract</description>
    <arm_group_label>PRP gel application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with perianal fistula

          -  signing the informed consent form

          -  above the age of 18

        Exclusion Criteria:

          -  inflammatory bowel disease

          -  previous radiation therapy

          -  having connective tissue disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barış Sevinç, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uşak University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barış Sevinç, M.D.</last_name>
    <phone>+905054880511</phone>
    <email>drbarissevinc@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nurullah Damburacı, M.D.</last_name>
    <phone>905058726249</phone>
    <email>nurullahdamburaci@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uşak University</name>
      <address>
        <city>Uşak</city>
        <zip>64100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barış Sevinç</last_name>
      <phone>5054880511</phone>
      <email>drbarissevinc@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 2, 2019</study_first_submitted>
  <study_first_submitted_qc>December 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2019</study_first_posted>
  <last_update_submitted>December 4, 2019</last_update_submitted>
  <last_update_submitted_qc>December 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uşak University</investigator_affiliation>
    <investigator_full_name>Barış Sevinç</investigator_full_name>
    <investigator_title>Assoc. Prof.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

